Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of PF-07258669 with Itraconazole and Food in Adults
NCT06706869Phase 1Completed
- Sponsor
- Pfizer
- Start
- Dec 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of PF-07258669 in unintentional weight loss (3 arms), sponsored by Pfizer. Primary endpoints: Maximum Observed Plasma Concentration, Area Under the Curve From Time Zero to Last Quantifiable Concentration and 1 more. Started Dec 2024; status: completed.
02
Drugs
PF-07258669
03
Conditions
unintentional weight loss
Beyond the preview
Go deeper on NCT06706869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06706869.